Suspension of trading
Valuation Axonics, Inc.
Stocks
AXNX
US05465P1012
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.98 USD | +0.75% |
|
-.--% | - |
| 19/11/24 | Axonics, Inc.(NasdaqGS:AXNX) dropped from S&P Healthcare Equipment Select Industry Index | CI |
| 19/11/24 | Axonics, Inc.(NasdaqGS:AXNX) dropped from S&P Global BMI Index | CI |
Company Valuation: Axonics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 420.1 | 940.7 | 1,987 | 2,593 | 3,097 | 3,153 |
| Change | - | 123.9% | 111.26% | 30.46% | 19.46% | 1.79% |
| Enterprise Value (EV) 1 | 286.1 | 782.4 | 1,778 | 2,382 | 2,749 | 2,835 |
| Change | - | 173.45% | 127.2% | 34.01% | 15.4% | 3.14% |
| P/E | -3.26x | -9.9x | -33.6x | -30.1x | -48.9x | -502x |
| PBR | 2.93x | 5.17x | 6.94x | 5.38x | 5.43x | 4.96x |
| PEG | - | 0.2x | 0.7x | -1.2x | 1.6x | 5.6x |
| Capitalization / Revenue | 594x | 68.1x | 17.8x | 14.4x | 11.3x | 8.61x |
| EV / Revenue | 405x | 56.6x | 15.9x | 13.2x | 10x | 7.74x |
| EV / EBITDA | -9.17x | -9.85x | -34.2x | -40.9x | -90.5x | 365x |
| EV / EBIT | -8.9x | -9.71x | -33.1x | -35.3x | -65.3x | -602x |
| EV / FCF | -12.6x | -14x | -26.9x | -118x | 60.5x | -416x |
| FCF Yield | -7.91% | -7.14% | -3.72% | -0.85% | 1.65% | -0.24% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -4.642 | -2.798 | -1.485 | -1.859 | -1.279 | -0.124 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.707 | 13.82 | 111.5 | 180.3 | 273.7 | 366.4 |
| EBITDA 1 | -31.19 | -79.41 | -52.02 | -58.27 | -30.36 | 7.775 |
| EBIT 1 | -32.14 | -80.6 | -53.76 | -67.39 | -42.08 | -4.712 |
| Net income 1 | -32.48 | -79.94 | -54.92 | -80.07 | -59.7 | -6.088 |
| Net Debt 1 | -134 | -158.3 | -209.6 | -210.5 | -348.1 | -317.3 |
| Reference price 2 | 15.11 | 27.71 | 49.92 | 56.00 | 62.53 | 62.23 |
| Nbr of stocks (in thousands) | 27,805 | 33,948 | 39,809 | 46,297 | 49,530 | 50,662 |
| Announcement Date | 3/5/19 A | 3/4/20 A | 3/1/21 A | 3/1/22 A | 3/1/23 A | 2/29/24 A |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 3.63B | |
| 25.69x | 4.91x | 17.18x | 1.1% | 125B | |
| 18.64x | 2.37x | 9.09x | 2.74% | 12.77B | |
| -164.56x | 13.48x | -499.83x | -.--% | 8.71B | |
| 19.8x | 9.31x | 15.08x | 2.16% | 4.07B | |
| 17.39x | 4.66x | 9.1x | 3.52% | 1.67B | |
| 88.77x | 14.2x | 49.62x | 0.06% | 1.46B | |
| Average | 0.95x | 8.15x | -66.63x | 1.6% | 22.5B | |
| Weighted average by Cap. | 14.69x | 5.39x | -12.59x | 1.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AXNX Stock
- Valuation Axonics, Inc.
Select your edition
All financial news and data tailored to specific country editions
